Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2026-01-25 @ 5:52 PM
Study NCT ID:
NCT03322657
Status:
COMPLETED
Last Update Posted:
2021-11-16
First Post:
2017-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
Sponsor:
The Cleveland Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
17-764
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None